4 free views remaining today
osteogenesis imperfecta type 2
ICD-10 Codes
Related ICD-10:
Description
Osteogenesis imperfecta (OI) type II, also known as brittle bone disease, is a severe form of the genetic disorder that affects the body's ability to build strong bones.
Characteristics of OI Type II:
- Most severe form: OI type II is considered the most severe and life-threatening form of osteogenesis imperfecta.
- Short arms and legs: Babies born with this condition often have very short arms and legs, which can lead to difficulties in movement and mobility.
- Small chest: The rib cage may be abnormally small, fragile, and underdeveloped, leading to complications such as underdeveloped lungs.
- Soft skull: In some cases, the skull may be soft and fragile, increasing the risk of fractures.
Complications:
- Respiratory problems: The underdeveloped lungs can lead to respiratory issues, making it difficult for individuals with OI type II to breathe properly.
- Increased risk of fractures: The bones are extremely fragile and prone to breaking, which can cause significant pain and discomfort.
- Reduced mobility: The short arms and legs, combined with the fragility of the bones, can make everyday activities challenging.
Prognosis:
Unfortunately, OI type II is a lethal form of osteogenesis imperfecta, meaning that it can be life-threatening. The severity of the condition and the associated complications often lead to a poor prognosis.
References:
- [1] Type II. Most severe type. A baby has very short arms and legs, a small chest, and soft skull. He or she may be born with fractured bones ...
- [2] Type II is the most serious form of osteogenesis imperfecta. It causes severe complications, like underdeveloped lungs (due to poor rib cage development), ...
- [3] Osteogenesis imperfecta type II is a lethal type of osteogenesis imperfecta (OI), a genetic disorder characterized by increased bone fragility, low bone mass ...
Additional Characteristics
- Reduced mobility
- Respiratory problems
- Increased risk of fractures
- Short arms and legs
- Small chest
- Soft skull
- Brittle bone disease
Signs and Symptoms
Osteogenesis imperfecta (OI) type II, also known as brittle bone disease, is a severe form of the condition that affects multiple systems in the body. The signs and symptoms of OI type II can be quite distinct and are often present at birth or shortly after.
Physical Characteristics
- A baby with OI type II may have very short arms and legs, a small chest, and a soft skull [1].
- They may also be born with fractured bones, which can be a sign of the condition [6].
Respiratory Complications
- The most severe forms of OI type II can include an abnormally small, fragile rib cage, leading to underdeveloped lungs [7].
- This can cause breathing problems and make it difficult for the baby to breathe properly [3].
Musculoskeletal Symptoms
- OI type II is characterized by numerous broken bones that develop before birth while the fetus is still in the womb [3].
- After birth, babies with OI type II may experience frequent or unexplained bone fractures, which can be a sign of the condition [6].
Other Complications
- The symptoms of OI type II can worsen over time and cause severe headaches, changes in facial sensation, lack of control over muscle movements, and difficulty speaking [4].
- In some cases, babies with OI type II may experience hearing loss, brittle teeth, bone deformities such as bowed legs or scoliosis, and short stature [8].
Early Detection
- A prenatal ultrasound can show broken or abnormally shaped bones in a fetus, which can be an early sign of OI type II [6].
- If you suspect that your baby may have OI type II, it's essential to consult with a healthcare professional for proper diagnosis and treatment.
References:
[1] Context result 1 [2] Context result 3 [3] Context result 3 [4] Context result 4 [5] Context result 6 [6] Context result 6 [7] Context result 7 [8] Context result 8
Additional Symptoms
- Hearing loss
- Severe headaches
- Difficulty speaking
- Underdeveloped lungs
- Changes in facial sensation
- Lack of control over muscle movements
- Very short arms and legs
- Small chest
- Soft skull
- Fractured bones at birth
- Abnormally small, fragile rib cage
- Frequent or unexplained bone fractures
- Brittle teeth
- Bone deformities (e.g. bowed legs, scoliosis)
- short stature
- breathing problems
Diagnostic Tests
Osteogenesis imperfecta (OI) type 2, also known as brittle bone disease, is a severe form of OI that affects the bones and teeth. Diagnosing OI type 2 can be challenging, but various tests can help confirm the condition.
Prenatal Diagnosis Prenatal diagnosis of OI type 2 may be suggested by fetal ultrasound appearances, particularly limb-length abnormalities, which can be detected as early as 15-18 weeks' gestation [6]. Genetic testing of amniocytes can confirm the presence of OI type 2. This is a crucial step in providing genetic counseling and preparing for the birth of a child with this condition.
Genetic Testing Genetic testing is essential to diagnose OI type 2. A blood or skin sample can be sent to a lab for collagen or genetic testing, which usually confirms whether a person has OI [2]. Next-generation sequencing can detect single nucleotide and copy number variants in 25 genes associated with OI, including those responsible for type 2 [9].
Physical Exam A physical exam by a healthcare provider is also crucial in diagnosing OI type 2. The doctor will take your child's complete prenatal, birth, and family medical history. Tools for diagnosing OI can include:
- Physical examination to assess bone fragility and other symptoms
- Radiological studies (e.g., X-rays) to evaluate bone density and structure
- Genetic testing to confirm the presence of OI type 2
Other Diagnostic Tests In addition to genetic testing, other diagnostic tests may be used to diagnose OI type 2. These include:
- Collagen testing: This test can detect abnormalities in collagen production, which is often associated with OI.
- Bone density testing: This test measures bone mineral density and can help assess the severity of OI.
It's essential to note that a combination of these tests may be used to confirm the diagnosis of OI type 2. A healthcare provider will work with you to determine the best course of action for your child.
References: [1] Not provided (initial query) [2] Dec 20, 2021 — Healthcare providers may send blood or skin samples to a lab for collagen or genetic testing. [6] Mar 18, 2024 — Antenatal US is most useful in evaluating OI types II and III. [9] ... This test utilizes next-generation sequencing to detect single nucleotide and copy number variants in 25 genes associated with osteogenesis imperfecta (OI) ...
Additional Diagnostic Tests
- Physical Exam
- Genetic Testing
- Bone density testing
- Prenatal Diagnosis
- Collagen testing
Treatment
Treatment Options for Osteogenesis Imperfecta Type 2
Osteogenesis imperfecta (OI) type 2, also known as brittle bone disease, is a rare genetic disorder characterized by extremely fragile bones that break or fracture easily. While there is no cure for OI, various treatment options are available to manage the symptoms and prevent deformities.
Bisphosphonate Therapy
One of the most commonly used treatments for OI type 2 is bisphosphonate therapy. Bisphosphonates are a class of medications that help strengthen bones and prevent fractures by slowing down bone loss. These drugs, such as pamidronate, are typically administered intravenously (IV) every few weeks.
- According to search result [3], IV pamidronate is effective in babies and can be used to relieve pain in severe cases.
- Search result [5] states that bisphosphonate medicines help strengthen bones and prevent fractures, which may be used in most types of OI.
- A study mentioned in search result [7] found that bisphosphonates have been widely used in the treatment of children and adults with OI, although there is good evidence that they increase bone mineral density (BMD).
Other Treatment Options
In addition to bisphosphonate therapy, other treatment options for OI type 2 may include:
- Fracture care: This involves managing fractures and preventing deformities.
- Surgery: In some cases, surgery may be necessary to correct skeletal deformities or stabilize the spine.
- Physical therapy: Physical therapy can help improve mobility and
Recommended Medications
- Surgery
- Physical therapy
- Bisphosphonate Therapy
- Fracture care
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
The differential diagnosis for osteogenesis imperfecta (OI) type 2 involves considering other conditions that may present with similar symptoms, such as:
- Idiopathic juvenile osteoporosis: This is a rare condition characterized by low bone density and increased risk of fractures in children and adolescents [6].
- Hypophosphatasia: A genetic disorder that affects the mineralization of bones, leading to softening and weakening of bones [6].
- Celiac disease: An autoimmune disorder that can cause malabsorption of nutrients, including calcium and vitamin D, which are essential for bone health [6].
In children and adolescents with fractures, these conditions should be considered in the differential diagnosis of OI type 2. However, it's worth noting that OI type 2 is a severe form of osteogenesis imperfecta, characterized by underdeveloped lungs due to poor rib cage development, among other complications.
According to [3], the differential diagnosis for OI type 2 may also include other conditions such as:
- OI type I: The most common form of osteogenesis imperfecta, which is generally less severe than OI type 2.
- OI type IV: Another form of osteogenesis imperfecta that can present with similar symptoms to OI type 2.
It's essential to consider these differential diagnoses when evaluating patients with suspected OI type 2, as accurate diagnosis and treatment are crucial for managing the condition effectively.
Additional Differential Diagnoses
- OI type I
- OI type IV
- hypophosphatasia
- celiac disease
- idiopathic juvenile osteoporosis
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_4695
- owl#annotatedSource
- t366244
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0110341
- core#notation
- DOID:0110341
- oboInOwl#hasDbXref
- MIM:166210
- IAO_0000115
- An osteogenesis imperfecta that is characterized by bone fragility and perinatal lethality and has_material_basis_in dominantly inherited mutations in the COL1A1 gene on chromosome 17q21.33 or the COL1A2 gene on chromosome 7q21.3.
- oboInOwl#hasExactSynonym
- Vrolik type of osteogenesis imperfecta
- rdf-schema#label
- osteogenesis imperfecta type 2
- rdf-schema#subClassOf
- t365965
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000147
- relatedICD
- http://example.org/icd10/Q78.0
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.